Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections. The finding, published in the journal, Immunity, may lead to earlier intervention ...
Apr 8, 2024
0
25
Planes, trains, boats, automobiles and even feet. During the past decades and centuries, global travel and human migration have made all of us more worldly—from our broadening awareness of the world beyond our birthplaces, ...
Mar 27, 2024
0
25
A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that injecting engineered dendritic cells directly into cancerous lung tumors can help promote a stronger immune response, causing more ...
Mar 26, 2024
0
0
Cutting-edge bioluminescence technology pioneered at The University of Western Australia has been used to uncover a potential game-changer in immunotherapy.
Mar 20, 2024
0
42
University of Queensland researchers have discovered how the "on-switch" for the body's inflammation machinery can get stuck and cause rare genetic inflammatory diseases. Professor Kate Schroder and her team at UQ's Institute ...
Mar 19, 2024
0
36
Catherine Wu has been a pioneer in a promising approach to fight cancer: vaccines that target specific immune-stimulating molecules, known as immunogenic peptides, generated by the distinct genetic mutations of any individual ...
Apr 16, 2024
0
0
Examining the immune cells in the environment around a tumor could help to predict how a person's cancer might progress and respond to treatment, according to new research led by UCL and the Francis Crick Institute.
Apr 10, 2024
0
0
TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous cell cancer (HNSCC), according ...
Apr 9, 2024
0
14
A recent Northwestern Medicine study has discovered a previously unknown molecular mechanism that supports antitumor responses and cell survival in cytotoxic immune cells, according to findings published in the Journal of ...
Apr 9, 2024
0
1
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0
